{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:06:07Z","timestamp":1793473567194,"version":"4.5.0"},"reference-count":25,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"10","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2025,10,16]]},"DOI":"10.1167\/tvst.14.10.25","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:30:40Z","timestamp":1760621440000},"page":"25","source":"Crossref","is-referenced-by-count":3,"title":["SS-OCT\/OCTA Assessment of Choroidal Structure in Vitreoretinal Lymphoma Patients and Their Changes During Intravitreal Methotrexate Chemotherapy"],"prefix":"10.1167","volume":"14","author":[{"given":"Xinyi","family":"Zhou","sequence":"first","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixue","family":"Liu","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"Gu","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[{"name":"Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China"},{"name":"NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China"},{"name":"Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/OPTH.S159014","article-title":"Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.","volume":"13","author":"Venkatesh","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-022-01356-7","article-title":"Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.","volume":"15","author":"Chen","year":"2022","journal-title":"J Hematol Oncol"},{"key":"bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000446605","article-title":"Histopathologic diagnosis of atypical primary vitreoretinal lymphoma following enucleation.","volume":"2","author":"Sood","year":"2016","journal-title":"Ocul Oncol Pathol"},{"key":"bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/IAE.0000000000002676","article-title":"Histologic findings in vitreoretinal lymphoma: learning from enucleation specimens.","volume":"40","author":"Albadri","year":"2020","journal-title":"Retina"},{"key":"bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ajo.2023.03.010","article-title":"Longitudinal analysis of ocular manifestation and interleukin during intravitreal treatment of vitreoretinal lymphoma with methotrexate.","volume":"251","author":"Gu","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/ceo.14197","article-title":"Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.","volume":"51","author":"Guan","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12886-019-1300-1","article-title":"Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"bib9","doi-asserted-by":"crossref","first-page":"101053","DOI":"10.1016\/j.preteyeres.2022.101053","article-title":"Challenges in the diagnosis and management of vitreoretinal lymphoma\u2014clinical and basic approaches.","volume":"90","author":"Takase","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12886-024-03438-1","article-title":"Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up.","volume":"24","author":"Maggio","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"bib11","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/IAE.0000000000003579","article-title":"Perivascular flower-bud-like lesions on en face optical coherence tomography angiography in patients with vitreoretinal lymphoma.","volume":"42","author":"Chen","year":"2022","journal-title":"Retina"},{"key":"bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajo.2021.11.023","article-title":"Advanced OCT analysis of biopsy-proven vitreoretinal lymphoma.","volume":"238","author":"Pichi","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"bib13","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1097\/IAE.0000000000002260","article-title":"Ultra-widefield multimodal imaging of primary vitreoretinal lymphoma.","volume":"39","author":"Lavine","year":"2019","journal-title":"Retina"},{"key":"bib14","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s10792-021-01828-8","article-title":"Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.","volume":"41","author":"Rishi","year":"2021","journal-title":"Int Ophthalmol"},{"key":"bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12886-015-0127-7","article-title":"Changes of choroidal structure after treatment for primary intraocular lymphoma: retrospective, observational case series.","volume":"15","author":"Egawa","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/09273948.2019.1616769","article-title":"Retinal and choroidal changes of vitreoretinal lymphoma from active to remission phase after intravitreal rituximab.","volume":"28","author":"Cicinelli","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"bib17","doi-asserted-by":"crossref","first-page":"e0260469","DOI":"10.1371\/journal.pone.0260469","article-title":"Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS One"},{"key":"bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09273948.2018.1533984","article-title":"Immunohistochemical and immunocytochemical analyses in patients with vitreoretinal lymphoma.","volume":"28","author":"Kase","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1167\/iovs.04-0869","article-title":"Murine model of primary intraocular lymphoma.","volume":"46","author":"Chan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib20","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1167\/iovs.07-0008","article-title":"Impaired th1\/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.","volume":"48","author":"Touitou","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s10384-024-01102-1","article-title":"Clinical features and multimodal imaging of primary choroidal lymphoma.","volume":"68","author":"Goto","year":"2024","journal-title":"Jpn J Ophthalmol"},{"key":"bib22","doi-asserted-by":"crossref","first-page":"100829","DOI":"10.1016\/j.preteyeres.2020.100829","article-title":"Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index.","volume":"77","author":"Agrawal","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"bib23","doi-asserted-by":"crossref","first-page":"698644","DOI":"10.3389\/fmed.2021.698644","article-title":"Widefield swept-source optical coherence tomography angiography assessment of choroidal changes in Vogt-Koyanagi-Harada disease.","volume":"8","author":"Qian","year":"2021","journal-title":"Front Med"},{"key":"bib24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1080\/09273948.2018.1530364","article-title":"Choroidal vascularity index and choroidal thickness in human leukocyte antigen-B27-associated uveitis.","volume":"27","author":"Kim","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/09273948.2019.1678650","article-title":"Choroidal vascular changes in multiple evanescent white dot syndrome.","volume":"29","author":"Pellegrini","year":"2021","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2810971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:30:43Z","timestamp":1760621443000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2810971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.14.10.25","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}